E-LIB Suche - Ergebnisse für: García Campelo, María Rosario

1

Mobocertinib in previously treated patients with EGFR exon ..:

Popat, Sanjay ; Ramalingam, Suresh ; Zhou, Caicun...
Lung Cancer. 178 (2023) - p. S35 , 2023

2

Difficulties on the access to innovative targeted therapies..:

Calvo, Virginia ; Camps, Carlos ; Carcereny, Enric...
Clinical and Translational Oncology. 26 (2023) 3 - p. 597-612 , 2023

Link: https://doi.org/10.1007/..

3

Efficacy of Lorlatinib in Treatment-Naive Patients With ALK..:

Bearz, Alessandra ; Martini, Jean-François ; Jassem, Jacek...
Journal of Thoracic Oncology. 18 (2023) 11 - p. 1581-1593 , 2023

Link: https://doi.org/10.1016/..

4

Characterization and management of adverse events observed ..:

Yang, James Chih-Hsin ; Zhou, Caicun ; Jänne, Pasi A....
Expert Review of Anticancer Therapy. 23 (2022) 1 - p. 95-106 , 2022

Link: https://doi.org/10.1080/..

5

Mobocertinib (TAK-788) in epidermal growth factor receptor ..:

Popat, Sanjay ; Ramalingam, Suresh ; Kim, Tae Min...
Lung Cancer. 165 (2022) - p. S30-S31 , 2022

Link: https://doi.org/10.1016/..

6

DUART: Durvalumab After Radiotherapy in Patients with Unres..:

Filippi, Andrea R ; Dziadziuszko, Rafał ; García Campelo, Maria Rosario...
Future Oncology. 17 (2021) 34 - p. 4657-4663 , 2021

Link: https://doi.org/10.2217/..

7

Health-related quality of life in the randomized phase III ..:

Garcia Campelo, Maria Rosario ; Lin, Huamao M. ; Zhu, Yanyan...
Lung Cancer. 155 (2021) - p. 68-77 , 2021

Link: https://doi.org/10.1016/..

8

Efficacy and safety of Nivolumab in older patients with pre..:

Arias Ron, David ; Areses Manrique, Maria Carmen ; Mosquera Martínez, Joaquín...
Journal of Geriatric Oncology. 12 (2021) 3 - p. 410-415 , 2021

Link: https://doi.org/10.1016/..

9

PD-L1 Inhibitors as Monotherapy for the First-Line Treatmen..:

García Campelo, María Rosario ; Arriola, Edurne ; Campos Balea, Begoña...
Journal of Clinical Medicine. 10 (2021) 19 - p. 4583 , 2021

Link: https://doi.org/10.3390/..

10

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advance..:

Camidge, D. Ross ; Kim, Hye Ryun ; Ahn, Myung-Ju...
Journal of Thoracic Oncology. 16 (2021) 12 - p. 2091-2108 , 2021

Link: https://doi.org/10.1016/..

11

Stem cell and lung cancer development: blaming the Wnt, Hh ..:

García Campelo, María Rosario ; Curbera, Guillermo Alonso ; Gallego, Guadalupe Aparicio..
Clinical and Translational Oncology. 13 (2011) 2 - p. 77-83 , 2011

Link: https://doi.org/10.1007/..

12

Pretreatment Tissue TCR Repertoire Evenness Is Associated w..:

Casarrubios, Marta ; Cruz-Bermúdez, Alberto ; Nadal, Ernest...
Clinical Cancer Research. 27 (2021) 21 - p. 5878-5890 , 2021

Link: https://doi.org/10.1158/..

13

Capmatinib plus nazartinib in patients with EGFR-mutated no..:

Felip, Enriqueta ; Metro, Giulio ; Soo, Ross A....
European Journal of Cancer. 208 (2024) - p. 114182 , 2024

Link: https://doi.org/10.1016/..

14

First-line nivolumab plus ipilimumab for metastatic non-sma..:

Ready, Neal E ; Audigier-Valette, Clarisse ; Goldman, Jonathan W...
Journal for ImmunoTherapy of Cancer. 11 (2023) 2 - p. e006127 , 2023

Link: https://doi.org/10.1136/..

15

PD-L1 Inhibitors as Monotherapy for the First-Line Treatmen..:

García Campelo, María Rosario ; Arriola, Edurne ; Campos Balea, Begoña...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509645/. , 2021

Link: http://www.ncbi.nlm.nih...